Designing Longevity
Skip to main content

Compare Medicines for Chronic Idiopathic Constipation

Chronic idiopathic constipation, or CIC, describes persistent constipation without an identified underlying cause. Polyethylene glycol is a guideline-supported starting option. When over-the-counter approaches provide inadequate relief, prescription options differ in how they work, what their trials measured and the side effects to discuss.

Sources reviewed November 13, 2026 · How we work

Over-the-counter polyethylene glycol 3350 powder

PEG is a nonpeptide osmotic laxative that keeps water in the stool. The joint AGA and ACG guideline strongly recommends PEG for adult CIC and reports evidence of benefit that lasted six months in a study. Possible side effects include bloating, loose stools, gas and nausea.

MiraLAX is an over-the-counter example with bottles and single-serve packets. Its package directions cover occasional constipation and tell readers to ask a doctor about use beyond one week. Compare unit prices using the same quantity of active ingredient, and discuss ongoing use with a clinician.

Sources for this section

Compare two equal-size PEG bottles

Target’s up&up Powderlax had the lower listed bottle price when we checked both 26.9 oz listings on November 13, 2026. It was $17.99 (Target item 15087763), and MiraLAX was $30.99 (item 14896180), or about $0.40 versus $0.69 per dose before taxes and delivery. Check the current price for your store.

The two listings are unflavored, nonpeptide PEG 3350 powders, with about 45 labeled doses per bottle.

The bottle size lets you compare prices. Both labels cover occasional constipation. Ask a clinician before using an over-the-counter laxative for more than one week.

Sources for this section

Linzess (linaclotide) 72 or 145 mcg, 30 capsules

Both strengths appear in the adult CIC label. In two trials of the 145 mcg capsule, 20% versus 3% on placebo and 15% versus 6% met the bowel response. It required at least three complete spontaneous bowel movements and at least one more than baseline per week for at least 9 of 12 weeks.

A separate adult trial supported the 72 mcg presentation. Diarrhea is a key adverse effect, and severe diarrhea is a labeled warning. The 290 mcg adult IBS-C trial results address a different diagnosis and outcome.

Sources for this section

Trulance (plecanatide) 3 mg, 30 tablets

In the two adult CIC trials, 21% met the sustained bowel response in each Trulance group, compared with 10% and 13% in the respective placebo groups. The definition required improvement for at least 9 of 12 weeks, including at least 3 of the last 4 weeks.

The joint guideline recommends plecanatide for adults with CIC who do not respond to over-the-counter agents. Diarrhea is the most common adverse reaction. Its adult IBS-C trials answer a separate question about combined pain and bowel improvement.

Sources for this section

Amitiza (lubiprostone) 24 mcg, 60 capsules

Lubiprostone increases intestinal fluid secretion. In two four-week placebo-controlled CIC studies, adults taking Amitiza reported more spontaneous bowel movements in week one. These trials used bowel frequency as their main measure.

The joint guideline conditionally suggests lubiprostone after an inadequate response to over-the-counter agents. Nausea and diarrhea are common side effects in the CIC studies.

Sources for this section

Motegrity (prucalopride) tablets

Prucalopride is a nonpeptide medicine that stimulates movement in the colon. Among six trials summarized in the label, five reported a statistically significant difference from placebo in the share of adults averaging at least three complete spontaneous bowel movements per week across 12 weeks. The label lists 1 mg and 2 mg tablets, with 30-tablet bottles.

Headache, abdominal pain, nausea and diarrhea are among its common adverse reactions. The label calls for monitoring new or worsening depression or suicidal thoughts or behavior.

Sources for this section

Compare treatment and access for the same diagnosis

Fiber and some stimulant laxatives also have a guideline role. Symptoms such as persistent straining or a sense of blockage can prompt an evaluation for a pelvic floor disorder, where treatment may include biofeedback. Trial percentages above use different populations or thresholds and cannot rank the products.

For a prescription, confirm the plan’s CIC criteria and obtain a price for the exact strength, quantity and refill interval. Some plans place generic lubiprostone or prucalopride on a different tier from the brand. A low advertised copay can depend on a specific plan or savings program.

Sources for this section
Explore Gut Health & Digestion